Currently, there is a Standard Treatment Guideline and Essential Medicines List (STG/EML) available for use by health workers at public health care settings in Eswatini; which was published in 2012. Considering the numerous changes in policies, guidelines, and new scientific evidence that informs clinical practice, there is a compelling need to revise and update this guideline so that it remains relevant to the users. It’s widely believed that the current STG has not been used extensively due to a number of factors. TSP/SC-PASS has obtained approval from the Principal Secretary, MOH, Eswatini to support the review, update of the treatment guideline and hereby wishes to engage the services of competent consultant(s) to undertake some aspects of this project as specified below.
More than 120 people from 11 countries across three continents attended the 20th Baylor International Pediatric AIDS Initiative (BIPAI) network meeting from November 12-16, 2018, in Johannesburg, South Africa. The annual network meeting brings together clinicians, program managers, monitoring and evaluation (M&E) staff, and other key cadres to learn from each other and exchange experiences for improved healthcare programming and service delivery.
Welcome to our fourth issue of the research digest. The digest offers article abstracts from peer-reviewed literature related to HIV and AIDS in southern Africa and is designed to keep you in touch with the rapidly expanding evidence base pertaining to HIV in the region.
INTRODUCTION: The Global Fund and the US President's Emergency Plan for AIDS Relief (PEPFAR) are major donors to HIV services with key populations (KPs) to achieve the UNAIDS 95-95-95 epidemic control goals.
Africa is far off track in reducing new HIV infections among children and young people and is unlikely to reduce new infections in young people substantially before 2030 due to an anticipated doubling of the adolescent population, according to findings from a UNICEF modelling exercise presented o
People who started HIV treatment in Swaziland under a universal test and treat policy were seven times more likely to still be in care and to have a fully suppressed viral load six months after starting treatment when compared to management of patients under the existing standard of care, Velephi